Patent · US Active

Compositions and methods for inhibiting intimal hyperplasia

US9480666B2 · kind B2 · utility

1Cited by

2References

18Claims

0Family size

Assignees

Tobias Deuse · DE
Sonja Schrepfer · DE

Inventors

Tobias Deuse · Hamburg, DE
Sonja Schrepfer · San Mateo, US

Key dates

Filing date	Apr 20, 2015
Grant date	Nov 1, 2016
Priority date	—
Expiry date	Apr 20, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K31/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods are provided for preventing, inhibiting, or treating intimal hyperplasia in a patient who has undergone a coronary bypass procedure that include providing a solution comprising DCA added to water; and administering the solution orally to a patient to prevent, inhibit, or treat intimal hyperplasia.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.